The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Investigation of Some Antiviral N-Heterocycles as COVID 19 Drug: Molecular Docking and DFT Calculations
Open accessAbstract
The novel coronavirus, COVID-19, caused by SARS-CoV-2, is a global health pandemic that started in December 2019. The effective drug target among coronaviruses is the main protease Mpro, because of its essential role in processing the polyproteins that are translated from the viral RNA. In this study, the bioactivity of some selected heterocyclic drugs named Favipiravir (1), Amodiaquine (2), 2′-Fluoro-2′-deoxycytidine (3), and Ribavirin (4) was evaluated as inhibitors and nucleotide analogues for COVID-19 using computational modeling strategies. The density functional theory (DFT) calculations were performed to estimate the thermal parameters, dipole moment, polarizability, and molecular electrostatic potential of the present drugs; additionally, Mulliken atomic charges of the drugs as well as the chemical reactivity descriptors were investigated. The nominated drugs were docked on SARS-CoV-2 main protease (PDB: 6LU7) to evaluate the binding affinity of these drugs. Besides, the computations data of DFT the docking simulation studies was predicted that the Amodiaquine (2) has the least binding energy (−7.77 Kcal/mol) and might serve as a good inhibitor to SARS-CoV-2 comparable with the approved medicines, hydroxychloroquine, and remdesivir which have binding affinity −6.06 and −4.96 Kcal/mol, respectively. The high binding affinity of 2 was attributed to the presence of three hydrogen bonds along with different hydrophobic interactions between the drug and the critical amino acids residues of the receptor. Finally, the estimated molecular electrostatic potential results by DFT were used to illustrate the molecular docking findings. The DFT calculations showed that drug 2 has the highest of lying HOMO, electrophilicity index, basicity, and dipole moment. All these parameters could share with different extent to significantly affect the binding affinity of these drugs with the active protein sites.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244 · cited 2×
“That specification is according to the phylogenetic analysis and genome structure of coronaviruses [3].”
BackgroundAutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 25,486
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., Liu, X., Zhao, L., Dong, E., Song, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa237 · Cited by 2,662
Liu, J., Cao, R., Xu, M., Wang, X., Zhang, H., Hu, H., Li, Y., Hu, Z., Zhong, W., & Wang, M. (2020) · Cell Discovery · doi:10.1038/s41421-020-0156-0 · Cited by 2,070
Sheahan, T. P., Sims, A. C., Leist, S. R., Schäfer, A., Won, J., Brown, A. J., Montgomery, S. A., Hogg, A., Babusis, D., Clarke, M. O., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13940-6 · Cited by 1,738
Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2
Zhou, Y., Hou, Y., Shen, J., Huang, Y., Martin, W., & Cheng, F. (2020) · Cell Discovery · doi:10.1038/s41421-020-0153-3 · Cited by 1,597
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Warren, T. K., Jordan, R., Lo, M. K., Ray, A. S., Mackman, R. L., Soloveva, V., Siegel, D., Perron, M., Bannister, R., Hui, H. C., et al. (2016) · Nature · doi:10.1038/nature17180 · Cited by 1,556
Potential interventions for novel coronavirus in China: A systematic review
Zhang, L., & Liu, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25707 · Cited by 1,348
Liu, C., Zhou, Q., Li, Y., Garner, L. V., Watkins, S. P., Carter, L. J., Smoot, J., Gregg, A. C., Daniels, A. D., Jervey, S., et al. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00272 · Cited by 1,297
Devaux, C. A., Rolain, J.-M., Colson, P., & Raoult, D. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105938 · Cited by 1,099
Serial interval of novel coronavirus (COVID-19) infections
Nishiura, H., Linton, N. M., & Akhmetzhanov, A. R. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.02.060 · Cited by 1,083
Favipiravir (T-705), a novel viral RNA polymerase inhibitor
Furuta, Y., Gowen, B. B., Takahashi, K., Shiraki, K., Smee, D. F., & Barnard, D. L. (2013) · Antiviral Research · doi:10.1016/j.antiviral.2013.09.015 · Cited by 1,072
N-Heterocyclic carbene metal complexes in medicinal chemistry
Oehninger, L., Rubbiani, R., & Ott, I. (2013) · Dalton Trans. · doi:10.1039/c2dt32617e · Cited by 560
COVID-19: a new challenge for human beings
Yang, P., & Wang, X. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0407-x · Cited by 452
Chan, K. W., Wong, V. T., & Tang, S. C. W. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x20500378 · Cited by 398
Bi-directional differentiation of single bronchioalveolar stem cells during lung repair
Liu, K., Tang, M., Liu, Q., Han, X., Jin, H., Zhu, H., Li, Y., He, L., Ji, H., & Zhou, B. (2020) · Cell Discovery · doi:10.1038/s41421-019-0132-8 · Cited by 360
The $2.6 Billion Pill — Methodologic and Policy Considerations
Avorn, J. (2015) · New England Journal of Medicine · doi:10.1056/nejmp1500848 · Cited by 318
Grimstein, M., Yang, Y., Zhang, X., Grillo, J., Huang, S.-M., Zineh, I., & Wang, Y. (2019) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.10.033 · Cited by 317
Systematic review of amodiaquine treatment in uncomplicated malaria
Olliaro, P., Nevill, C., LeBras, J., Ringwald, P., Mussano, P., Garner, P., & Brasseur, P. (1996) · The Lancet · doi:10.1016/s0140-6736(96)06217-4 · Cited by 283
Computational network biology: Data, models, and applications
Liu, C., Ma, Y., Zhao, J., Nussinov, R., Zhang, Y.-C., Cheng, F., & Zhang, Z.-K. (2020) · Physics Reports · doi:10.1016/j.physrep.2019.12.004 · Cited by 227
Zhou, A., Liu, C., Garner, L., Watkins, S., Smoot, J., Daniels, A., Li, Y., Carter, L., Gregg, A., Jervey, S., et al. (2020) · doi:10.1021/scimeetings.0c07113 · Cited by 227
Xavier, S., Periandy, S., & Ramalingam, S. (2015) · Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy · doi:10.1016/j.saa.2014.08.039 · Cited by 225
The clinical pharmacology of ribavirin.
Glue, P. (1999) · PubMed · Cited by 217
Cheng, F., Hong, H., Yang, S., & Wei, Y. (2016) · Briefings in Bioinformatics · doi:10.1093/bib/bbw051 · Cited by 99
Therapeutic opportunities to manage COVID-19/SARS-CoV-2 infection: Present and future
Sethu, S., Shetty, R., Ghosh, A., Honavar, S. G., & Khamar, P. M. (2020) · Indian Journal of Ophthalmology · doi:10.4103/ijo.ijo_639_20 · Cited by 91
Drug Repurposing: New Treatments for Zika Virus Infection?
Cheng, F., Murray, J. L., & Rubin, D. H. (2016) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2016.09.006 · Cited by 75
In Silico Oncology Drug Repositioning and Polypharmacology
Cheng, F. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8868-6_15 · Cited by 62
Alnoman, R. B., Parveen, S., Hagar, M., Ahmed, H. A., & Knight, J. G. (2019) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2019.1701555 · Cited by 45
Self-citationShawon, J., Khan, A. M., Rahman, A., Hoque, M. M., Halim, M. A., Sarwar, M. G., & Halim, M. A. (2016) · Interdisciplinary Sciences Computational Life Sciences · doi:10.1007/s12539-016-0186-3 · Cited by 39
Role of Resultant Dipole Moment in Mechanical Dissociation of Biological Complexes
Kouza, M., Banerji, A., Koliński, A., Buhimschi, I. A., & Kloczkowski, A. (2018) · Molecules · doi:10.3390/molecules23081995 · Cited by 28
Sato, R., Vohra, S., Yamamoto, S., Suzuki, K., Karpov, P. A., Shulga, S., Blume, Y. B., & Kurita, N. (2020) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2020.107611 · Cited by 23
Cited by
C, S., S., D. K., Ragunathan, V., Tiwari, P., A., S., & P, B. D. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1815584 · Cited by 375
Metadata
- Authors
- Hagar, M., Ahmed, H. A., Aljohani, G., & Alhaddad, O. A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2020-05-30
- Volume
- 21
- Issue
- 11
- Pages
- 3922
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W3030817098
- Cited by
- 294
- References
- 33
- FWCI
- 18.82
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.